Celadon Pharmaceuticals Plc (AIM:CEL)
London · Delayed Price · Currency is GBP · Price in GBX 13.40
+1.90 (16.52%)
Jul 1, 2025, 7:30 AM GMT+1
Celadon Pharmaceuticals Market Cap
Celadon Pharmaceuticals has a market cap or net worth of 9.23 million as of July 28, 2025. Its market cap has decreased by -82.08% in one year.
Market Cap
9.23M
Enterprise Value
14.01M
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
13.40
Market Cap Chart
Since March 29, 2022, Celadon Pharmaceuticals's market cap has decreased from 89.42M to 9.23M, a decrease of -89.68%. That is a compound annual growth rate of -50.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 9.23M | -10.67% |
| Dec 31, 2024 | 10.33M | -86.01% |
| Dec 29, 2023 | 73.84M | 137.10% |
| Dec 30, 2022 | 31.14M | -65.17% |
| Mar 29, 2022 | 89.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| GSK plc | 56.21B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.21B |
| Oxford Nanopore Technologies | 2.02B |